Share >  
Share
Share on Tumblr

Venkat Jasti

News »

   latest by relevance
Suven Life Sciences aims to achieve 20% growth ahead
Jun 01, 2011 at 15:59 | Source: CNBC-TV18
Venkat Jasti, CEO of Suven Life Sciences in an interview with CNBC-TV18 spoke about the performance of the company and the road ahead.
Suven gets 4 product patents for several key markets
May 26, 2011 at 11:35 | Source: Moneycontrol.com
Suven Life Science Monday said it has got product patent for its new chemical entity, 5-HT compounds used to treat neurodegenerative diseases like Parkinson and Schizophrenia from Europe, New Zealand, Australia and Korea.
Suven Life gears up for phase-2 trial of Alzheimer's drug
May 18, 2011 at 15:26 | Source: CNBC-TV18
Venkat Jasti, CEO of Suven Life Sciences says that the company is now preparing for the next level phase-2 of clinical trial, for its molecule that will help treatment of Alzheimer's disease and schizophrenia.
आय में 50 करोड़ रु की बढ़तः सुवेन लाइफसाइंसेज
Apr 06, 2011 at 11:25 | Source:
यूएसएफडीए से मंजूरी के बाद पाशमैलाराम यूनिट से आय में 50 करोड़ रुपये की बढ़त की उम्मीद है।
Have received 15 product patents in 2010: Suven Life
Dec 23, 2010 at 16:52 | Source: CNBC-TV18
In an interview with CNBC-TV18, Venkat Jasti, CEO, Suven Life Sciences, spoke about the latest happenings in his company and sector.
Suven Lifesciences to firm up fund-raising plans in Q4
Nov 09, 2010 at 15:49 | Source: CNBC-TV18
The promoters of Suven Lifesciences have hiked their stake in the company by 2.4% to 63.28%. In an interview with CNBC-TV18, Venkat Jasti, CEO, Suven Life Sciences shed light on the promoter stake hike in the company, its fund raising plans and gave perspective on the business outlook for the current fiscal.

Videos »
Suven Life Sciences aims to achieve 20% growth ahead
Suven Life gears up for phase-2 trial of Alzheimer's drug
Have received 15 product patents in 2010: Suven Life
Suven Lifesciences to firm up fund-raising plans in Q4
Talking to 3 major pharma cos for a JV: Suven Life
more »

Photos »

  /  
Interact & exchange stock tips & market info »

Guest

Suven Life Scie  

JUST THEY HAD INTERVIEW OF VENKAT JASTI..ON ZEE RESULTS ...

2.16 PM May 4th

RAMESHABC

Silver Member

2 Followers

Suven Life Scie  

SUVEN IS A CLASSIC CASE OF RAPSCALLION PROMOTERS LOOTING THE PUBLIC. T...

5.18 PM Apr 9th

arcadiastoc
ks82

Platinum Member

505 Followers

Suven Life Scie  

of these molecules may be out-licensed at various phases of clinical ...

4.57 PM Apr 3rd

Related News »
Suven Life Secures 4 Product Patents For Their NCEs
CEO Venkat Jasti said, 'We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need and an estimated $30 billion market potential globally."
May 22, 2012 at 07:32 | Source: RTT News
Suven Life Sciences Ltd. : Suven Life Sciences secures 4 Product Patents for their NCEs in Japan, Australia, Europe and Eurasia
"We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need and an estimated $30 billion market potential globally" says Venkat Jasti ...
May 22, 2012 at 08:15 | Source: 4-traders (press release)

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window